Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.

Inclusion Criteria: * Signed informed consent. * Age ≥ 1 year. * Both genders. * Clinical picture of acute bacterial conjunctivitis defined by: Conjunctival secretion and conjunctival bulbar hyperemia Exclusion Criteria: * Pregnant women, lactating or planning to become pregnant. * Women of reproductive age and who do not have a hormonal contraceptive method, intrauterine device or bilateral tubal obstruction. * Participation in another clinical research study ≤ 30 days before the baseline visit. * Previous participation in this same study. * That they can not comply with their attendance at appointments or with all the requirements of the protocol. * Single eye * Presence of corneal abrasion or corneal ulceration in the study eye. * History Users of contact lenses who are not willing to suspend their use during the study. * Users of any formulation with ophthalmic application, including lubricants, that can not, or do not want to suspend it during the study. * Antecedents of eye surgery 6 weeks prior to study entry. * Viral or allergic conjunctivitis. * Active uveitis. * Active ulcerative keratitis. * Recurrent corneal erosion syndrome * Antecedent of hypersensitivity or allergy to fluoroquinolones.